Current Month 2009
Article Features
  Many Women Who Survived Childhood Cancer Do Not Undergo Recommended Breast Cancer Screening
Tinkering with the Circadian Clock Can Suppress Cancer Growth
Early Mammograms May Have Net Harm in Some BRCA Mutation Carriers
Hispanic Women and Breast Cancer
Genetic 'Hotspot' for Breast Cancer Risk in Asian Women
Study Finds High Level of Medical Mistrust Among Minority Women Impacts Quality of Healthcare
New Guidelines Emphasize Use of Breast MRI to Supplement Standard Imaging
Multivitamin Use May Offer No Cancer Reduction Benefit in Postmenopausal Women
New Genomic Test Can Personalize Breast Cancer Treatment
Study Finds Pregnancy Has No Impact on Breast Cancer Survival But Can Delay Treatment, Diagnosis
19% of Women Do Not Receive Recommended Radiation after Mastectomy
Statin Therapy Ineffective in Breast Cancer Prevention

Breast Cancer Risk Rapidly Declines after Women Stop Taking Postmenopausal Combined Hormone Therapy

Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published in The New England Journal of Medicine.

"These findings support the hypothesis that the recent reduction in breast cancer incidence in the United States is predominantly related to a decrease in combined estrogen plus progestin use," said Rowan T. Chlebowski, M.D., Ph.D., a LA BioMed chief investigator and lead author for the study.

Read More of the Main Article

Visit the Ezine

Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon